Bayer moves to dismiss US monopolization case over genetically modified seeds
( July 13, 2026, 17:54 GMT | Official Statement) -- MLex Summary: Bayer CropScience moved to dismiss US antitrust claims accusing it of unlawfully monopolizing the seed market, arguing the complaint relies on impermissible group pleading that lumps all defendants together and fails to sufficiently allege who did what. Bayer said nothing prevents Latham Quality or other market participants from using Bayer’s publicly available know-how to develop their own, generic seed.See attached file. ...
Prepare for tomorrow’s regulatory change, today
MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.
Know what others in the room don’t, with features including:
- Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
- Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
- Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
- Curated case files bringing together news, analysis and source documents in a single timeline
Experience MLex today with a 14-day free trial.